Different Smoking Statuses on Survival and Emphysema in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Qi Ding,Jie Li,Shudi Xu,Yanzhong Gao,Youmin Guo,Baozhu Xie,Hua Li,Xia Wei
DOI: https://doi.org/10.2147/COPD.S346456
2022-03-05
International Journal of COPD
Abstract:Qi Ding, 1, &ast Jie Li, 1, &ast Shudi Xu, 1 Yanzhong Gao, 2 Youmin Guo, 3 Baozhu Xie, 1, 4 Hua Li, 1, 4 Xia Wei 1 1 Department of Pulmonary and Critical Care Medicine, The Ninth Hospital of Xi'an Affiliated with Xi'an Jiaotong University, Xi'an, Shaanxi; 2 Department of Radiology, The Ninth Hospital of Xi'an affiliated with Xi'an Jiaotong University, Xi'an, Shaanxi; 3 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi; 4 The Medical School of Yan'an University, Yan'an, Shaanxi &astThese authors contributed equally to this work Correspondence: Xia Wei, Department of Pulmonary and Critical Care Medicine, The Ninth Hospital of Xi'an affiliated with Xi'an Jiaotong University, Xi'an, Shaanxi, Tel +18891991910, Email Objective: To investigate the association between different smoking statuses and survival and emphysema in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: This retrospective study included patients admitted from October 2014 to September 2017. Demographic, clinical, laboratory, imaging, impulse oscillometry, and traditional pulmonary function data were collected. The relationship between smoking and EI was analyzed via binary logistic regression after adjusting for other factors. Survival was analyzed using the Kaplan–Meier method and the log rank test. Results: The patients with AECOPD (357 cases) were identified (and stratified into three groups: never smoked (NS; n=83), former smokers (FS, n=118), and current smokers (CS; n=156). Compared with CS, NS were older and predominantly female. No differences were observed in respiratory symptoms and acute exacerbation between CS and NS. NS had higher resistance and reaction in the central and peripheral airways, while CS exhibited more severe diffuse dysfunction. CS demonstrated more severe and extensive emphysema. Smoking was an independent risk factor for emphysema after adjusting for age, forced expiratory volume in the first second over predicted value, BMI, leukocyte count, and carbon monoxide transfer coefficient. No difference in 5-year survival rates between NS and CS was established. Conclusion: CS has the worst pulmonary function, suggesting a more important destruction of the lung parenchyma, while AECOPD without smoking risk factors mostly affects the airways. Impulse oscillometry can be used for imaging airway-dominant AECOPD. There was no difference in the 5-year survival rate. Keywords: chronic obstructive pulmonary disease, acute exacerbation, smoking, impulse oscillometry system, emphysema index Chronic obstructive pulmonary disease (COPD) is projected to be the third leading cause of death worldwide, 1 with the health impact and economic cost of COPD posing a dual burden to society. 2 COPD is a complex chronic inflammatory disease involving central airways, small airways, lung tissue, and pulmonary vessels, 3 presenting heterogeneous characteristics. COPD is associated with a variety of risk factors (the main one being smoking, but also including genetic factors, family history of COPD, indoor/outdoor air pollution, inflammatory conditions, infections, medications, diet, and snoring) 3,4 though more than 20% of COPD patients have never smoked. 5 The same factors are also associated with response to treatment and prognosis. 3,4 There are specific etiological characteristics and risk factors for COPD in China, including an estimated 312 million Chinese who are smoking. 6 Previous studies showed that cigarette smoking and second-hand smoking are important risk factors for COPD. 7,8 Other risk factors include biofuel combustion, ambient air pollution, underweight, childhood chronic cough, and parental history of respiratory diseases. 7 It is unclear, however, whether different risk factors result in different clinical and pathological features. Furthermore, it is unknown whether COPD caused by different pathogenic risk factors has different prognostic outcomes and these issues deserve more exploration. Patients having an acute exacerbation of COPD (AECOPD) have a 5-year survival of 50% after hospitalization for exacerbation. 3 Treatment of AECOPD requires different treatment modalities and vast medical resources. Although many studies addressed stable COPD, data about AECOPD is scarcer. While clinical and laboratory investigations, pulmonary function tests, and computed tomography (CT) can reveal some characteristics, no single modality can adequately represent the disease's full spect -Abstract Truncated-